280 related articles for article (PubMed ID: 26660178)
21. Testing human blood for cannabis by GC-MS.
Kintz P; Cirimele V
Biomed Chromatogr; 1997; 11(6):371-3. PubMed ID: 9413618
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH).
Baird SN; Frazee CC; Garg U
J Appl Lab Med; 2023 Jul; 8(4):665-673. PubMed ID: 37071885
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum.
Purschke K; Heinl S; Lerch O; Erdmann F; Veit F
Anal Bioanal Chem; 2016 Jun; 408(16):4379-88. PubMed ID: 27116418
[TBL] [Abstract][Full Text] [Related]
24. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
25. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations.
Franz T; Skopp G; Schwarz G; Musshoff F
Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743
[TBL] [Abstract][Full Text] [Related]
26. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
[TBL] [Abstract][Full Text] [Related]
27. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
[TBL] [Abstract][Full Text] [Related]
28. Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine.
Musshoff F; Daldrup T
Int J Legal Med; 1991; 104(5):263-6. PubMed ID: 1664232
[TBL] [Abstract][Full Text] [Related]
29. A fast and reliable method for quantitation of THC and its 2 main metabolites in whole blood by GC-MS/MS (TQD).
Castro AL; Tarelho S; Melo P; Franco JM
Forensic Sci Int; 2018 Aug; 289():344-351. PubMed ID: 29960257
[TBL] [Abstract][Full Text] [Related]
30. Improved and validated method for the determination of Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography-mass spectrometry.
Steinmeyer S; Bregel D; Warth S; Kraemer T; Moeller MR
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):239-48. PubMed ID: 12007768
[TBL] [Abstract][Full Text] [Related]
31. Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis.
Hart ED; Vikingsson S; Mitchell JM; Winecker RE; Flegel R; Hayes ED
J Anal Toxicol; 2022 May; 46(5):573-576. PubMed ID: 33987675
[TBL] [Abstract][Full Text] [Related]
32. Solid-phase extraction and GC-MS analysis of THC-COOH method optimized for a high-throughput forensic drug-testing laboratory.
Stout PR; Horn CK; Klette KL
J Anal Toxicol; 2001 Oct; 25(7):550-4. PubMed ID: 11599598
[TBL] [Abstract][Full Text] [Related]
33. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
[TBL] [Abstract][Full Text] [Related]
34. Novel solid-phase extraction protocol for 11-nor-9-carboxy-delta9-tetrahydrocannabinol from urine samples employing a polymeric mixed-mode cation-exchange resin, Strata-X-C, suitable for gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry analysis.
Huq S; Dixon A; Kelly K; Kallury KM
J Chromatogr A; 2005 May; 1073(1-2):355-61. PubMed ID: 15909541
[TBL] [Abstract][Full Text] [Related]
35. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography tandem mass spectrometry (GC/MS-MS).
Chiarotti M; Costamagna L
Forensic Sci Int; 2000 Oct; 114(1):1-6. PubMed ID: 10924845
[TBL] [Abstract][Full Text] [Related]
36. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.
Teixeira H; Verstraete A; Proença P; Corte-Real F; Monsanto P; Vieira DN
Forensic Sci Int; 2007 Aug; 170(2-3):148-55. PubMed ID: 17614225
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020.
Pandya V; Wilker C; Johnson-Davis KL
J Anal Toxicol; 2023 Jul; 47(6):495-503. PubMed ID: 37079848
[TBL] [Abstract][Full Text] [Related]
38. Hypochlorite adulteration of urine causing decreased concentration of delta 9-THC-COOH by GC/MS.
Baiker C; Serrano L; Lindner B
J Anal Toxicol; 1994; 18(2):101-3. PubMed ID: 8207929
[TBL] [Abstract][Full Text] [Related]
39. Distribution of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in traffic fatality cases.
Lin DL; Lin RL
J Anal Toxicol; 2005; 29(1):58-61. PubMed ID: 15808015
[TBL] [Abstract][Full Text] [Related]
40. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
